Eric Warren
Chief Commercial Officer at Mineralys Therapeutics, Inc. (MLYS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 22SEC | MLYSMineralys Therapeutics, Inc. | Sell Plan | 7,43838,400 held (−16%) | $28.12 | $209K | -27.8% |
| Aug 25SEC | MLYSMineralys Therapeutics, Inc. | Sell Plan | 7,43738,400 held (−16%) | $25.98 | $193K | -21.9% |
| Jul 23SEC | MLYSMineralys Therapeutics, Inc. | Sell Plan | 7,43838,400 held (−16%) | $26.87 | $200K | -24.5% |
| Jun 30SEC | MLYSMineralys Therapeutics, Inc. | Sell Plan | 104,12438,400 held (−73%) | $25.90 | $2.7M | -21.6% |
- Sell
Chief Commercial Officer Eric Warren sold $209K of MLYS at $28.12 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer Eric Warren sold $193K of MLYS at $25.98 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer Eric Warren sold $200K of MLYS at $26.87 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Commercial Officer Eric Warren sold $2.7M of MLYS at $25.90 — cuts the stake by 73%; pre-scheduled 10b5-1 plan sale.